On July 10, 2026, the Texas Department of State Health Services published a notice in the Texas Register (a government publication most people have never heard of and fewer have read) that set off a chain of legal consequences affecting an unknown number of Texans who had done nothing more than buy a product off a licensed retailer’s shelf. The notice, catalogued at 51 TexReg 4598, reinstated language from the agency’s 2021 controlled substances schedules covering tetrahydrocannabinols and marihuana extracts. The text is generic structural language. It does not name Delta-8, Delta-10, THCP, or HHC. Those compounds had been protected by a definitional safe harbor written into Texas law. Now that safe harbor has been stripped away. Not regulated more carefully. Not restricted to licensed dispensaries. Stripped, under DSHS’s reading, of the protection that had kept them out of the criminal code.
That the language reaches those specific compounds is DSHS’s reading of its own schedules. Whether that reading is correct is one of the live legal questions the resulting prosecutions will turn on. Everything in this piece that describes what these compounds are, or what the July 31 enforcement date means for them, treats that agency reading as the operative one, because that is what prosecutors will charge. The reading is contested.
Under both federal law and the Texas Controlled Substances Act (which mirrors the federal framework) all controlled substances are divided into categories called schedules, ranked by their accepted medical utility and their potential for abuse. Schedule I is the most serious classification: substances the government has determined have no accepted medical use and a high potential for abuse, the same category as heroin. Separately, the Texas Controlled Substances Act organizes criminal offenses into penalty groups, each carrying its own sentencing ranges. Tetrahydrocannabinols other than marihuana have been in Penalty Group 2 by legislative statute for decades, alongside PCP and MDMA. The relationship between scheduling and penalty groups, and precisely what the July 10 notice changed about that relationship under DSHS’s reading, is where the criminal exposure in these cases actually comes from.
The Texas Legislature voted to delegate this scheduling authority to DSHS and reserved to itself the power to correct it by statute. It did not vote on this particular change. There was no press conference. A public comment process did occur when DSHS first proposed this language in 2020: a hearing was noticed, and a hearing was held in Austin in October 2020. No comments were received, in writing or at the hearing. The market that would be disrupted by this language did not yet exist at scale in 2020. What made the 2026 reinstatement possible was a Texas Supreme Court decision issued just weeks earlier, in a case called Texas Department of State Health Services v. Sky Marketing Corp. d/b/a Hometown Hero, which resolved a multi-year legal challenge to DSHS’s scheduling authority. The industry had weeks to adjust. The people who had already bought the products got nothing. And the legal mess that followed is, in several ways, more interesting than the policy debate that caused it.
How a Government Agency Got the Power to Criminalize a Product Without a Vote
To understand why this happened the way it did, you need to understand something about how drug laws actually work in Texas, because most people assume they work the way civics class described. The assumption is that the legislature passes a law, the governor signs it, and that becomes the rule. For most laws, that is accurate. For controlled substances, it is not quite right. The Texas Controlled Substances Act gives the Department of State Health Services the authority, under Tex. Health & Safety Code § 481.034, to add, remove, or move substances between schedules by administrative rule, without going back to the legislature for approval. The practical consequence is that the list of illegal drugs in Texas is not fixed by statute in the way most people think. It is a living document maintained by a state agency, and it can change faster than any legislature moves.
The reason DSHS ended up being the instrument of this policy rather than the legislature has a specific and well-documented history. The 89th Texas Legislative Session produced SB 3, a bill that would have banned all hemp-derived THC products in Texas. It passed both chambers. Governor Greg Abbott vetoed it on June 22, 2025, citing constitutional concerns: the bill’s total prohibition would put Texas law on a collision course with the 2018 federal Farm Bill and would likely be enjoined in court for years, rendering it unenforceable. He pointed specifically to Arkansas, where a similar law had been blocked in federal court and was rendering that state’s ban ineffective. The Arkansas injunction Abbott cited has since been overturned on appeal, a development that has not changed the outcome in Texas but does erode one of the stated rationales for the veto.
Abbott then called two special sessions to produce a replacement regulatory framework. Both deadlocked. No bill reached his desk. When the special sessions failed, Abbott issued Executive Order GA-56 on September 10, 2025, directing DSHS, the Texas Alcoholic Beverage Commission, and the Department of Public Safety to impose hemp restrictions through existing statutory authority: age gates, ID verification, and coordinated enforcement. Abbott’s stated reason for vetoing SB 3 was that criminalizing hemp products overnight would wipe out good-faith investment and make felons of veterans and patients. Ten months later, the agency route he chose produced substantially that outcome, with less legislative process and less public notice than a statute would have required.
When Sky Marketing resolved DSHS’s legal challenge in May 2026, the agency had both the authority and the political momentum to act on scheduling. The Texas Supreme Court’s holding was narrow and consequential: the court found it lacked jurisdiction to review the commissioner’s scheduling decision on the merits, because Tex. Health & Safety Code § 481.034(g) makes that determination final and unreviewable by courts unless the legislature acts to change it. The court did not hold that DSHS classified Delta-8 correctly. It held that no valid ultra vires claim existed to challenge the classification, because the statute insulates the commissioner’s judgment from judicial review. The court rendered judgment reversing the trial court’s order. The opinion issued May 1, 2026. The mandate issued June 5, 2026. The practical consequence of § 481.034(g) is significant: if DSHS’s reading of its own schedules is wrong, the only institution with authority to correct it is the Texas Legislature.
It is worth being precise about what the court held and what it did not. The holding was jurisdictional, not substantive. The court expressly noted that the vendors’ reading of the 2019 hemp law was plausible and rooted in the statutory text, and that the Farm Bill “could be read” to authorize these products. It declined to resolve that question because § 481.034(g) removed it from the court’s reach. The opinion also noted that the legislature, not the department, controls the criminal penalty groups, a point that matters for how the scheduling change translates into criminal exposure. DSHS has civil regulatory authority. Criminal enforcement belongs to police and prosecutors, the elected prosecutors across Texas’s 254 counties, each making independent charging decisions. The commissioner represented in the underlying proceedings that naturally occurring delta-8 at trace levels is tolerable, and that the agency’s concern was with manufactured delta-8 at concentrations far above naturally occurring levels. What those prosecutors do with the changed definition, and how broadly they read it, is a question the agency left unanswered when it published the notice.
Five weeks after the mandate, DSHS published its notice reinstating the 2021 schedule language. Schedule I, Item 31, covering Tetrahydrocannabinols, and Item 58, covering Marihuana Extract, were restored to their pre-injunction form. The 0.3 percent Delta-9 hemp carve-out survived in both items, as did the Item 23 exclusion of hemp under chapter 121 from the definition of marihuana. What was removed, under DSHS’s reading, was the protection for alternative isomers and structural variants above naturally occurring trace levels. The effective date does not appear in the notice itself. DSHS’s controlled substances schedule page lists July 31, 2026 as the enforcement date.
Guilty Until Proven Organic
Here is where the legal architecture gets genuinely strange, and where the people charged in these cases face a problem built into the statutory scheme itself. In a normal criminal case, the prosecution has to prove every element of the offense. The defense does not have to prove anything. That principle, the presumption of innocence and the burden of proof beyond a reasonable doubt, is foundational.
Hemp cases in Texas may work differently, because of a provision buried in the Health and Safety Code: § 481.184(a) explicitly states the State is not required to negate the hemp exemption in its pleadings or in its case-in-chief. That is the State’s position, and it is the position most prosecutors will take at arraignment. It is also a position worth contesting. Hemp is written into Texas law as an exclusion from the definition of marihuana, not as an affirmative exception under chapter 481. There is a real structural argument that hemp status is an element of the offense itself, not an exception the defense must raise. If that argument holds, § 481.184 does not reach it, and the prosecution carries the full burden of proving the substance falls outside the hemp definition just as it would prove any other element. That argument is not settled. Courts have not resolved it uniformly. But conceding the burden shift without contesting it hands the State something it has not necessarily earned.
The paper trail matters regardless of how that question resolves. If the court accepts the State’s reading of § 481.184(a), the defense must come forward with evidence that the product qualifies for the hemp exception or the exception does not exist as a legal matter. That means reconstructing a paper trail through two separate Texas agencies. The cultivation side requires lot crop permits from the Texas Department of Agriculture, GPS acreage records, and formal transport manifests. The retail side requires a DSHS Consumable Hemp Product license and documentation under the mandatory QR code and certificate of analysis rule. Only after that chain is introduced does the burden shift back to the prosecution to prove beyond a reasonable doubt that the product fails the hemp definition.
The receipt from the store does not accomplish this. The certificate of analysis on the package does not accomplish this alone. Critically, the state crime lab only analyzed the end-stage chemistry of the seized product. It did not verify the regulatory paper trail, and it cannot. Those records exist at the TDA and DSHS agency level. The defense must secure them through administrative subpoenas directed at the agencies themselves. The police department’s evidence locker will never contain the licensing and transport records required to raise the exception. That discovery request belongs in the first round, not the last.
The Mathematical Alchemy of a First-Degree Felony
This is the part of the statutory scheme that produces genuine disbelief when explained to people who have not read the statute, and it is worth taking a moment to work through the math carefully, because the numbers are not exaggerated. Under Texas law, the hemp exemption is defined by concentration: a product is legal if its Delta-9-THC content is at or below 0.3 percent of the product’s total dry weight. That is the threshold written into Tex. Agric. Code § 121.001. It is a ratio. It is a percentage. Before that math can run, however, there is a threshold question that the statute does not answer.
The 0.3 percent figure is expressed on a dry weight basis, a term borrowed directly from agricultural testing of raw plant biomass. Dry weight means the mass of a sample after moisture has been driven off. The convention exists because living plant material carries variable amounts of water, and water content would otherwise make concentration comparisons meaningless across different samples. It is a sensible metric for hemp flower or a raw plant extract. It is not a metric that was designed for finished consumer goods, and when applied to them it produces results the statute cannot have anticipated.
A distillate is already anhydrous. There is no moisture to remove, so dry weight and wet weight are the same number and the modifier does nothing. A seltzer presents the opposite problem: drive off the water and what remains is mostly cannabinoid and dissolved sweetener, which means the literal dry weight THC ratio approaches a figure that bears no relationship to what the consumer is ingesting. A gummy sits somewhere between the two, depending on what the analyst decides counts as moisture in a gelatin matrix. The same statutory phrase, applied to three different product formats, produces three different methodological problems. The statute does not specify how to resolve any of them. The regulatory notice does not either. The result is that the lab must invent a convention to produce a number at all, and that convention lives in the standard operating procedure of whichever crime lab is running the analysis. Whether Harris County’s lab has documented and validated that convention for each matrix type is a discovery question. The 0.3 percent threshold is not a fact the state can simply assert for a finished edible. It is a calculation that depends on a methodological choice that has to be disclosed and defended. With that predicate established, the 8-pound math is worth running.
An 8-pound baked good (a tray of brownies, a large batch of muffins, whatever the product is) weighs approximately 3,628,739 milligrams. At 0.3 percent concentration, that product can legally contain 10,886 milligrams of active Delta-9-THC. To put that in perspective, a standard recreational dose is roughly 10 milligrams. That means a fully legal, concentration-compliant hemp product can contain more than one thousand recreational doses and still be on the right side of the law.
Now here is where the two parts of the statute collide. The concentration formula determines whether the product is legal. A completely separate provision, Tex. Health & Safety Code § 481.002(49), determines how a drug possession charge is graded: by the aggregate weight of the entire product, including everything mixed into it, not just the active compound. That means the flour, the sugar, the chocolate, the butter. Texas law calls these non-drug ingredients adulterants and diluents. Under the adulterant and diluent doctrine, prosecutors are not required to isolate the controlled substance and weigh it. They weigh the whole product. Every legal ingredient mixed into the batch is legally treated as part of the drug weight. If that 8-pound batch of muffins tips even fractionally over the 0.3 percent threshold, the state does not weigh the cannabinoid. The state weighs the muffins.
Tetrahydrocannabinols other than marihuana have been in Penalty Group 2 of the Texas Controlled Substances Act by statute for decades. That is a legislative classification, separate from the DSHS scheduling authority. What the July 31 enforcement date marks is not the creation of criminal exposure from scratch. Under DSHS’s reading, it marks the removal of the definitional protection that had kept these hemp-derived isomers out of that penalty group. Once that protection is gone, the existing statutory penalty structure applies automatically.
Possession of more than 400 grams of a Penalty Group 2 substance is a first-degree felony under § 481.116, carrying five to ninety-nine years in prison. Deferred adjudication is generally available, but judge-ordered community supervision is unavailable where a sentence exceeds ten years, and the penalty range itself begins at five. Eight pounds is 3,628 grams. That is nearly nine times the 400-gram threshold. The same math applies to a case of twelve infused seltzer cans, which weighs roughly nine pounds. These products were sold openly at licensed retailers weeks before the July 31 enforcement date. Aggregate weight has no bearing on whether a product is lawful under the hemp definition. Concentration determines that. But the moment a product is deemed noncompliant, aggregate weight becomes the only number that matters.
Co-Elution and the Deceptive Chromatogram
The state’s case in most of these prosecutions rests on a laboratory report identifying a specific cannabinoid compound above a specific concentration threshold. That report looks authoritative. It arrives on official letterhead with instrument data attached. The distinction between a measurement and a fact matters here, and the forensic mechanics of how these compounds are identified is where that distinction lives. To understand the limitation, it helps to understand what an isomer actually is. Delta-8, Delta-9, Delta-10, and exo-THC are all built from the exact same atoms: the same number of carbon atoms, hydrogen atoms, and oxygen atoms, assembled in the same basic ring structure. The only difference between them is where one specific chemical bond sits along that ring. Think of it like the same set of Lego bricks snapped together in slightly different configurations. The finished structures look nearly identical, they weigh exactly the same, and they are made of identical parts. But they are not the same molecule, and they do not behave the same way in the body. Delta-9 is the primary psychoactive compound in cannabis. Delta-8 produces a milder effect. Delta-10 is milder still. THCP is estimated to bind to cannabinoid receptors with significantly greater potency than Delta-9. Same atoms. Dramatically different legal and pharmacological consequences. The difference between Delta-8 and Delta-9 after July 31 is the difference between a product that retains the hemp carve-out and one that does not. The instruments state labs use, gas chromatography-mass spectrometry (GC-MS) and its liquid-phase counterpart LC-MS, work by separating the components of a sample and then identifying each component based on how it breaks apart under specific conditions. They are powerful, well-validated tools for many applications. For THC isomers specifically, they have a significant structural limitation that follows directly from what isomers are. Because the underlying molecular formula is identical across all four compounds, all four share a molecular mass of 314 grams per mole, and because they are structural isomers, they produce virtually indistinguishable fragmentation patterns when struck by the instrument’s electron beam. The instrument cannot tell them apart by mass alone. It can only distinguish them by when they exit the separation column, a value called retention time, and only if the analytical method gives them enough time and column distance to fully separate before they reach the detector. If the run time is compressed or the method was not developed with these specific isomers in mind, the compounds co-elute: they exit the column at nearly the same time, their detector signals overlap, and the instrument reports whichever compound the analyst configured it to find. The raw chromatogram is the actual graphical output of the separation. It will show whether that separation was clean or not. The summary report will not. The raw chromatogram is the evidence.
The Injector Port Creates the Controlled Substance
The second problem with GC-MS in these cases is more fundamental, and it is the kind of thing that stops analytical chemists mid-sentence when they first encounter it in a litigation context. To run a sample through a gas chromatograph, the sample has to be vaporized. That happens in the injector port, which operates at temperatures between 250 and 300 degrees Celsius. At those temperatures, a compound called THCA (tetrahydrocannabinolic acid) undergoes a chemical transformation called thermal decarboxylation. It loses a carboxyl group and physically converts into Delta-9-THC before it ever reaches the separation column. THCA is not a controlled substance. It occurs naturally in cannabis plants. It is not psychoactive. But the injector port heat does not care about any of that. The conversion is total and instantaneous. The native Delta-9-THC already present in the sample and the newly converted Delta-9-THC created from the THCA register as one single, merged peak on the chromatogram. The raw ratio data is physically destroyed inside the machine. That is the information that would allow an analyst to distinguish what the defendant actually possessed from what the instrument created. The only way to prevent this is through a process called chemical derivatization: treating the sample with a blocking agent before injection to protect the THCA molecule from the heat. Most high-throughput state crime labs skip this step entirely. When they do, the lab reports a single, inflated Delta-9-THC concentration that was partly created inside the instrument. The controlled substance on the lab report is, in part, an artifact of the analytical method. The legal implication is direct: if the concentration that pushes a product over the legal threshold was generated inside the injector port, the defendant did not possess that concentration. The instrument did.
The Reference Standard Problem
The third problem involves the newer compounds: THCP, HHC, and the other exotic structural variants that have flooded the market in recent years. Forensic identification of any compound requires a reference standard, meaning a chemically certified, highly pure sample of the target compound that the instrument can be calibrated against. For well-established controlled substances, those reference standards have existed for decades. For novel cannabinoids, the supply chain is thin. ISO 17034 Certified Reference Materials (the internationally recognized standard for analytical reference substances) are not available for every compound the reinstated schedule language now reaches. If a state lab is identifying THCP or HHC without a validated, multi-point calibration curve built from a certified reference material for that specific compound, the identification is not a measurement. It is an inference. A well-documented, scientifically rigorous inference, perhaps. But an unvalidated one that does not meet the reliability requirements for scientific evidence under Texas Rule of Evidence 702, and one that will not survive a properly conducted Daubert challenge. This information is not on the summary report. It is in the bench notes, the quality control records, and the instrument calibration files. All of it is discoverable.
The Muffin Has Another Problem: It Isn’t Uniform
Even if the lab correctly identifies the compound and accounts for the instrument’s thermal chemistry, there is a separate problem in how the sample was collected in the first place. Forensic analysts sampling a baked good or a food-matrix product typically perform what is called a grab sample. They take a fragment from one location in the product and use that fragment to represent the whole. This is a reasonable approach for a homogeneous substance, meaning one where the target compound is distributed evenly throughout. Baked goods are not homogeneous.
When a cannabinoid-infused fat is incorporated into a batter and baked, the fat migrates during the baking process. The result is concentration gradients: areas with higher cannabinoid density and areas with lower density. A sample taken from a fat-rich area will report a higher concentration than a sample taken from the crumb. If the analyst happened to sample a lipid hot spot, the concentration they report is not representative of the product’s average concentration, and the aggregate weight calculation built on that concentration overstates what the defendant actually possessed. There is no universally validated sampling protocol for edible matrices in most state lab standard operating procedures. Requesting the sampling methodology and the validation data for the matrix type is the discovery request that exposes this.
The second food-matrix problem is chemical rather than physical. The complex mixture of sugars, proteins, and fats in a food product interferes with the ionization process in LC-MS instruments, a phenomenon called ion suppression. Unvalidated extraction techniques, including acetonitrile shakes used for preliminary processing, produce concentration results that are not reproducible across different samples of the same product. If the lab’s method was not validated for the specific food matrix of the exhibit, the quantitative result does not have a known error rate, and a result without a known error rate is not a reliable measurement.
Where the Product Came From Changes the Legal Analysis Entirely
A significant share of the Delta-8 and Delta-9 products that were sold in Texas hemp stores did not come from cannabis flower processed into extract. They came from CBD isolate that was chemically converted into Delta-8 or Delta-9 through a process called acid-catalyzed isomerization. CBD isolate (the purified, non-psychoactive compound extracted from hemp) can be rearranged into Delta-8-THC by exposing it to an acid catalyst, typically a Lewis or Bronsted acid, which closes a ring in the molecular structure and repositions a double bond. The process is commercially dominant because CBD isolate is inexpensive to produce in bulk and Delta-8 commands a meaningful retail premium.
The legal question this raises is genuinely unsettled under current Texas law. The prosecution’s argument is that using commercial solvents and acid catalysts constitutes chemical synthesis, which means the product is a synthetic cannabinoid equivalent and falls outside the hemp safe harbor regardless of what the concentration reads. The defense argument is that the starting material was organic, naturally occurring CBD grown under a licensed Texas Department of Agriculture farm permit, and that rearranging the atoms of a compliant botanical extract is fundamentally different from synthesizing a compound like JWH-018 (a lab-designed synthetic cannabinoid with no plant origin at all). Under current Texas law, courts have not resolved that distinction. After November 12, Congress resolves it federally: Section 781 explicitly excludes cannabinoids that are synthesized, isomerized, or chemically converted outside the plant. That exclusion reaches acid-catalyzed Delta-8 directly. For conduct after that date, the federal answer is unambiguous. For conduct before it, the question remains open, and the defense argument carries real textual force.
What is resolved is the forensic signature. Acid-catalyzed cyclization is a chemically imprecise reaction. It leaves thermodynamic byproducts: residual Delta-8, unreacted CBD, and Delta-10 are all detectable on a properly run HPLC chromatogram. Before July 31, those byproducts were inconvenient. Under DSHS’s reading of the reinstated schedule language, they now function as statutory tripwires. A product that tests compliant for Delta-9 but shows trace Delta-8 on the chromatogram contains a Penalty Group 2 substance. The chromatogram that was evidence of a compliant product is now evidence of a felony, and the only way to evaluate which story it tells is to understand the chemistry of how the product was made.
The November 12 Cliff
None of this is static. The current situation has a hard endpoint: products still in the supply chain, prosecutions being filed against people who bought legal goods in June and July, labs calibrating their methods to a new statutory scheme. Federal H.R. 5371, Section 781, takes effect November 12, 2026. The amendment works by changing the statutory definition of hemp under the Agricultural Marketing Act of 1946, the federal law that Texas’s own Controlled Substances Act cross-references when drawing the line between legal hemp and illegal THC. When that federal definition changes, the Texas legal framework that depends on it shifts automatically.
Section 781 does not abandon dry weight. It sharpens it. The 0.3 percent threshold survives, but it now measures total THC including THCA, calculated after decarboxylation, and it applies to the plant, its derivatives, and intermediates throughout the supply chain. On top of that, a separate 0.4 milligram absolute cap applies to final retail products per innermost container. For finished goods sold at retail, the operative metric becomes absolute rather than relative. A gummy that passes the percentage test today may not clear a 0.4 milligram cap. A seltzer almost certainly does not. The shift from a relative concentration metric to an absolute per-container cap for finished retail products is worth reading as more than a policy preference. The dry weight percentage cannot be computed consistently across the range of finished goods the hemp market actually produces, as the preceding section describes. Congress is correcting that defect, at least for retail products, by replacing it with a metric that does not require the lab to invent a moisture convention for a distillate or a seltzer. Its arrival in November is an implicit acknowledgment that the current metric does not work for finished goods. For conduct after November 12, Section 781 also answers the isomerization question the preceding section raises: cannabinoids that are synthesized, isomerized, or chemically converted outside the plant are excluded from the federal definition of hemp, and the interstate shipping channels that have kept these products moving through the supply chain begin closing on that date.
Between now and November 12, Texas is the most legally volatile hemp market in the country. Prosecutors have a runway of roughly three months to bring cases against people who purchased products in the window before July 31, using labs that are still developing their methods, under a statutory scheme that turns a fraction-of-a-percent concentration difference into a potential life sentence. The injector port objection has a defined shelf life, and that shelf life ends November 12. Before that date, the thermal decarboxylation of THCA inside the instrument is a source of analytical error: a concentration created by the method, not possessed by the defendant. After that date, the decarboxylation is the intended measurement. Congress wrote it into the definition. Same instrument, same chemistry, opposite legal significance. Anyone charged for conduct before November 12 is being evaluated under a delta-9-only standard where the conversion is error. Anyone charged after is being evaluated under a standard where it is the point. The cases being filed right now fall entirely in the first category.
Why This Is Bigger Than a Drug Policy Debate
The Texas hemp cases are not primarily a story about marijuana politics or even about the wisdom of the agency’s July 10 reinstatement. They are a stress test for several foundational legal principles that have been underexamined for years. The ex post facto argument runs directly into the question of whether an administrative agency notice published in a government register constitutes the kind of law that the constitutional prohibition against punishing conduct that was legal when it occurred applies to. The due process argument is sharpened by what the Texas Supreme Court itself acknowledged: that the vendors’ reading of the hemp safe harbor was plausible and rooted in the statutory text. If the legal basis for believing these products were lawful was not only reasonable but textually grounded, the notice and fair warning questions become harder for the state to dismiss. The Daubert arguments ask whether GC-MS identification of specific THC isomers, without demonstrated chromatographic baseline separation between them, meets the scientific reliability standard for evidence in a criminal trial.
And the administrative law questions expose a structural asymmetry the court named but did not resolve: the opinion demands an unmistakable legislative statement before a controlled substance is removed from the schedules, but imposes no comparable requirement before an agency adds one. A single commissioner’s determination, unreviewable by courts under § 481.034(g) and correctable only by a legislature that has not invoked that mechanism, redrew the boundary between legal commerce and first-degree felony exposure for an entire industry.
One structural feature shapes what relief is realistically available when those cases are litigated. The Texas Supreme Court’s opinion flagged a concern about the breadth of the injunction that had protected this industry for four and a half years: a statewide injunction benefiting parties beyond those before the court raises distinct questions about the scope of permissible relief. The court did not issue a ruling on that point, but the caution is in the opinion. Any lawyer seeking a comparable injunction in future challenges should read that passage carefully, because the shelter that existed from 2021 to 2026 is unlikely to be replicated on the same terms.
These are not small questions. They are the kind of questions that produce published opinions, reshape the standards the whole defense bar works from, and occasionally produce Supreme Court cases. The cases that define how those doctrines develop are being filed right now.
Leave a Reply